Henry Schein (HSIC – Research Report) received a Buy rating and an $80.00 price target from Stifel Nicolaus analyst Jonathan Block today. The company’s shares closed yesterday at $75.64.
According to TipRanks, Block is a 5-star analyst with an average return of 9.9% and a 54.17% success rate. Block covers the Healthcare sector, focusing on stocks such as Henry Schein, Zoetis, and Elanco Animal Health.
Henry Schein has an analyst consensus of Hold, with a price target consensus of $74.00.
See Insiders’ Hot Stocks on TipRanks >>
Based on Henry Schein’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $3.16 billion and a net profit of $137 million. In comparison, last year the company earned a revenue of $3.07 billion and had a net profit of $150 million
Based on the recent corporate insider activity of 69 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of HSIC in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Henry Schein (HSIC) Company Description:
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial services on a non-recourse basis, e-services practice, technology, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
Read More on HSIC:
